RÉSUMÉ
Objective: To investigate the outcome and inlfuencing factors of graft vessels including saphenous vein graft (SVG) and left internal mammary artery graft (LIMAG) in patients after coronary artery bypass grafting (CABG). Methods: A total of 92 patients with post-CABG symptom recurrence from 2010 to 2015 were analyzed by angiography and clinical features for their native coronary vessel and graft vessel. There were 83 male and 9 female patients with the mean age of (62.6±10.8) years. The outcomes of graft vessel were assessed; correlation study was conducted between SVG, LIMAG lesions and traditional atherosclerosis risk factors like age, gender, hypertension, hyperlipidemia, diabetic mellitus, smoking, family history of coronary artery disease (CAD) with other clinical factors such as the time of angina recurrence, thetime from coronary angiography (CAG) to CABG, type of SVG (sequential graft or individual graft), the features of native target vessel lesions prior grafting. Results: The average time from CABG to symptom recurrence was (35.10±24.7) months. There were 146 grafts including 52 LIMAG and 94 SVG (60 individual and 34 sequential grafts), the patency rate of LIMAG was higher than SVG (63.5% vs 44.7%),P=0.030. SVG lesion was positively related to symptom recurrence (OR=1.119, 95% CI 1.002-1.249,P=0.046) and trended to female gender (P=0.065), while not related to other clinical factors; LIMGA lesion was not related to any clinical factors. The patency rate of sequential SVG was higher than individual SVG (58.9% vs. 36.7%,P=0.038). The native target vessel lesion (deifned by pre-operative occlusion/stenosis) was similar between individual SVG group (24/14) and no-lesion SVG group (17/5),P=0.388; while the native target vessel lesion in LIMAG group (7/12) was lower than no-lesion LIMAG group (23/10),P=0.04. Conclusion: Post-CABG lesion was not obviously related to traditional risk factors of CAD, post-SVG lesion was positively related to the time of post-CABG angina recurrence. SVG mid-and long-term patency in sequential graft vessel was higher than that in individual graft vessel. Pre-CABG native coronary blood lfow would affect the outcome of individual LIMAG but not SVG.
RÉSUMÉ
Objective To study the efifcacy of interferon IFN-αon chronic hepatitis B, analyze the inlfuencing factors of therapeutic effect. Methods 62 cases with hepatitis B collected in our hospital from January 2008 to December 2012 were treated with interferon IFN-αfor one year, and divided into response group and non-response group according to the efficacy, biochemical indicators, viral load, host factors of patients in both two groups were analyzed. Results After one year’s treatment, the response patients were 38 cases(61.29%), non-response patients were 24 cases(38.71%). The male to female ratio in response group was 26/12, 13/11 in non-response group. The mean disease duration in response group was (3.3 ± 1.3)years, (5.4 ± 1.4) years in non-response group. The mean age in response group was (31.9 ± 8.6) years, (32.7 ± 5.6) years in non-response group. The difference between two groups was statistically signiifcant(P<0.05) Conclusion There is good therapeutic effect for most patients. and no reply for some patients. Analysing clinical data and the results of the study, we found that the course of disease,age, male/female ratio and level of ALT and AST are inlfuencing factors in interferon IFN-αtreatment for chronic hepatitis B.They can be use to predict clinical effect of interferon IFN-αtreatment for chronic hepatitis B.